Applied DNA Sciences Inc. (APDN)
NASDAQ: APDN
· Real-Time Price · USD
3.90
-0.17 (-4.18%)
At close: Aug 15, 2025, 3:59 PM
3.92
0.38%
After-hours: Aug 15, 2025, 06:13 PM EDT
Applied DNA Sciences Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | 983.37K | 1.2M | 813.11K | 797.52K | 929.63K | 891.16K | 779.74K | 2.92M | 4.41M | 5.26M | 3.56M | 4.3M | 6.15M | 4.17M | 3.04M | 1.7M | 2.67M | 1.62M |
Cost of Revenue | 612.53K | 512.51K | 568.21K | 552.29K | 820.31K | 660.07K | 700.74K | 1.65M | 2.6M | 2.89M | 3.14M | 3.26M | 3.66M | 3.06M | 2.95M | 550.46K | 356.61K | 242.56K |
Gross Profit | 370.85K | 684.11K | 244.9K | 245.23K | 109.33K | 231.1K | 79K | 1.27M | 1.81M | 2.38M | 416.76K | 1.04M | 2.49M | 1.11M | 89.98K | 1.15M | 2.31M | 1.37M |
Operating Income | -3.46M | -2.96M | -3.27M | -3.35M | -3.62M | -3.79M | -4.17M | -2.86M | -2.7M | 1.42M | -4.37M | -2.84M | -1.99M | -4.63M | -4.46M | -3.37M | -2.32M | -2.97M |
Interest Income | 60.34K | 71.44K | 91.33K | 36.3K | 15.35K | 33.32K | 41.22K | 26.78K | 3.64K | 3.69K | 1.39K | n/a | 5.54K | 273.00 | n/a | 3.57K | 13.84K | n/a |
Pretax Income | -3.34M | -2.67M | -3.31M | 1.85M | -4.49M | -1.13M | -3.62M | -3.11M | 551.18K | -3.84M | -664.55K | -1.12M | -1.76M | -4.72M | -4.51M | -3.45M | -1.52M | -4.81M |
Net Income | -27.22M | -2.64M | -3.3M | 1.88M | -4.47M | -1.18M | -3.59M | -3.1M | 588.34K | -3.84M | -773.07K | -1.12M | -1.13M | -4.72M | -4.51M | -3.45M | -1.52M | -4.81M |
Selling & General & Admin | 2.98M | 2.63M | 2.68M | 2.68M | 3M | 3.08M | 3.31M | 3.29M | 3.52M | 2.63M | 3.87M | 3.01M | 3.41M | 4.66M | 2.31M | 3.24M | 3.56M | 3.5M |
Research & Development | 849.36K | 1.02M | 831.71K | 913.03K | 726.87K | 935.82K | 938.91K | 836.12K | 988.74K | 971.3K | 912.88K | 863.02K | 1.07M | 1.08M | 1.11M | 1.03M | 874.05K | 748.37K |
Other Expenses | n/a | n/a | n/a | n/a | 4.58K | -13.54K | -5.75K | -3.47K | 661.00 | 8.85K | n/a | n/a | n/a | n/a | -52.04K | -82.8K | -54.87K | -53.86K |
Operating Expenses | 3.83M | 3.65M | 3.52M | 3.59M | 3.73M | 4.02M | 4.25M | 4.13M | 4.51M | 3.6M | 4.79M | 3.88M | 4.48M | 5.74M | 3.73M | 4.52M | 4.63M | 4.35M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 872.08K | n/a | n/a | 5.44K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.19M | n/a | n/a | n/a |
Cost & Expenses | 4.45M | 4.16M | 4.08M | 4.14M | 4.55M | 4.68M | 4.95M | 5.78M | 7.11M | 6.48M | 7.93M | 7.13M | 8.14M | 8.8M | 6.68M | 5.07M | 4.99M | 4.59M |
Income Tax Expense | 23.89M | n/a | n/a | n/a | n/a | n/a | -23.39K | -14.43K | n/a | -874 | 108.51K | -1.76M | -632.35K | n/a | 1.7M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.77M | 31.52M | 17.74M | 4.01M | 871.32K | 13.67M | 678.44K | 645.43K | 645.43K | 640.56K | 565.82K | 485.03K | 404.23K | 374.31K | 374.73K | 361.75K | 361.75K | 272.9K |
Shares Outstanding (Diluted) | 1.77M | 31.52M | 17.74M | 4.01M | 871.32K | 13.67M | 678.44K | 645.43K | 645.43K | 645.43K | 565.82K | 485.03K | 404.23K | 374.31K | 374.73K | 361.75K | 361.75K | 272.9K |
EPS (Basic) | -15.35 | -0.56 | -0.19 | 0.47 | -5.13 | -1.8 | -5.29 | -4.8 | 0.91 | -6 | -1.37 | -2.32 | -2.79 | -12.61 | -12.04 | -9.53 | -4.19 | -17.62 |
EPS (Diluted) | -15.35 | -0.56 | -0.19 | 0.47 | -5.13 | -1.73 | -5.29 | -4.8 | 0.91 | -5.95 | -1.37 | -2.32 | -2.79 | -12.61 | -12.04 | -9.53 | -4.19 | -17.62 |
EBITDA | -3.46M | -2.91M | -3.19M | -3.21M | -3.43M | -3.49M | -3.84M | -2.51M | -2.36M | -880.06K | -3.92M | -2.54M | -1.83M | -4.39M | -3.43M | -3.19M | -2.12M | -2.88M |
EBIT | n/a | -2.96M | -3.27M | -3.35M | -3.62M | -3.79M | -4.17M | -2.86M | -2.7M | -1.22M | -4.37M | -2.86M | -2.15M | -4.71M | -3.64M | -3.44M | -2.32M | -2.97M |
Depreciation & Amortization | n/a | 58.58K | 76.98K | 134.16K | 186.33K | 298.95K | 329.68K | 349.15K | 344.5K | 338.92K | 327.68K | 321.19K | 320.86K | 320.75K | 299.87K | 247.77K | 199.38K | 97.41K |